<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2024.1373044</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>No causal association between pneumoconiosis and three inflammatory immune diseases: a Mendelian randomization study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Du</surname> <given-names>Yu-Jie</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0004"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Lu</surname> <given-names>Zhang-Wei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0004"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2633707/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Kai-Di</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Yi-Yu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname> <given-names>Hong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname> <given-names>Rong-Gui</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Jin</surname> <given-names>Xue</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Yi-Yuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Jing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Geng</surname> <given-names>An-Yi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2639043/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Li</surname> <given-names>Bao-Zhu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1187025/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Anhui Provincial Laboratory of Inflammatory and Immune Diseases</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Second Affiliated Hospital of Anhui Medical University</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0005">
<p>Edited by: Mohiuddin Md. Taimur Khan, Washington State University Tri-Cities, United States</p>
</fn>
<fn fn-type="edited-by" id="fn0006">
<p>Reviewed by: Ayse Malatyali, University of Central Florida, United States</p>
<p>Lang Tran, Institute of Occupational Medicine, United Kingdom</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Bao-Zhu Li, <email>lbz88730@163.com</email></corresp>
<fn fn-type="equal" id="fn0004">
<p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1373044</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Du, Lu, Li, Wang, Wu, Huang, Jin, Wang, Wang, Geng and Li.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Du, Lu, Li, Wang, Wu, Huang, Jin, Wang, Wang, Geng and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Objectives</title>
<p>To investigate the causal relationships between pneumoconiosis and rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and gout.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>The random-effects inverse variance weighted (IVW) approach was utilized to explore the causal effects of the instrumental variables (IVs). Sensitivity analyses using the MR-Egger and weighted median (WM) methods were did to investigate horizontal pleiotropy. A leave-one-out analysis was used to avoid the bias resulting from single-nucleotide polymorphisms (SNPs).</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>There was no causal association between pneumoconiosis and SLE, RA or gout in the European population [OR&#x2009;=&#x2009;1.01, 95% CI: 0.94&#x2013;1.10, <italic>p</italic>&#x2009;=&#x2009;0.74; OR&#x2009;=&#x2009;1.00, 95% CI: 0.999&#x2013;1.000, <italic>p</italic>&#x2009;=&#x2009;0.50; OR&#x2009;=&#x2009;1.00, 95% CI: 1.000&#x2013;1.001, <italic>p</italic>&#x2009;=&#x2009;0.55]. Causal relationships were also not found in pneumoconiosis due to asbestos and other mineral fibers and SLE, RA and gout [OR&#x2009;=&#x2009;1.01, 95% CI: 0.96&#x2013;1.07, <italic>p</italic>&#x2009;=&#x2009;0.66; OR&#x2009;=&#x2009;1.00, 95% CI: 1.00&#x2013;1.00, <italic>p</italic>&#x2009;=&#x2009;0.68; OR&#x2009;=&#x2009;1.00, 95% CI: 1.00&#x2013;1.00, <italic>p</italic>&#x2009;=&#x2009;0.20].</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>Our study suggests that pneumoconiosis may have no causal relationship with the three inflammatory immune diseases.</p>
</sec>
</abstract>
<kwd-group>
<kwd>inflammatory immune diseases</kwd>
<kwd>causal relationship</kwd>
<kwd>rheumatoid arthritis</kwd>
<kwd>systemic lupus erythematosus</kwd>
<kwd>gout</kwd>
</kwd-group>
<contract-num rid="cn1">81803310</contract-num>
<contract-num rid="cn2">2021zhyx-C21</contract-num>
<contract-num rid="cn3">JKS2022023</contract-num>
<contract-num rid="cn4">202304295107020026</contract-num>
<contract-sponsor id="cn1">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<contract-sponsor id="cn2">Research Fund of Anhui Institute of translational Medicine</contract-sponsor>
<contract-sponsor id="cn3">Center for Big Data and Population Health of IHM</contract-sponsor>
<contract-sponsor id="cn4">Clinical Medical Research Transformation Project in Anhui Province</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="40"/>
<page-count count="9"/>
<word-count count="4630"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Environmental health and Exposome</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>The inflammatory immune response is a vital immune defense mechanism. Tissues go through a normal process involving self-defense and damage repair when they are damaged, or infected by toxins or bacteria, or caused by other factors (<xref ref-type="bibr" rid="ref1">1</xref>). An excessive inflammatory immune response will cause body damage, leading to inflammatory immune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), gout, and so on. It has been a significant public health issue that has had a negative impact on both long-term social and economic development as well as human health. This class of disorders is characterized by systemic inflammatory immunological dysfunction, but the precise cause and mechanism are yet unknown. It has been revealed that occupational exposure to particulate matter and environmental variables are significant contributors to the pathogenesis of this disease.</p>
<p>Occupational populations might develop inflammatory immunological disorders. People exposed to silica, for instance, have a relative risk of RA that is more than three times higher (<xref ref-type="bibr" rid="ref2">2</xref>). Of those occupational populations with RA, SLE, and other disorders, 14.1% are extensively exposed to dust, chemicals, and other inorganic and organic pollutants. Immune disorders were substantially correlated with overall occupational environmental exposure [OR (95%CI)&#x2009;=&#x2009;1.29 (1.11&#x2013;1.49)] (<xref ref-type="bibr" rid="ref3">3</xref>). Exposure to inorganic dust, such as silica and asbestos, is the most likely cause of pneumoconiosis and further contributes to a relatively high incidence rate ratio of immune system diseases (1.99) (<xref ref-type="bibr" rid="ref3">3</xref>). And numerous epidemiological studies have demonstrated that pneumoconiosis has a strong correlation with the development of gout, RA, SLE, and other inflammatory immunological disorders. A nationwide cohort study had indicated that miners exposed to silica have an increased possibility of developing SLE and RA (<xref ref-type="bibr" rid="ref4">4</xref>). In Japan, reports regarding thirty cases of pneumoconiosis with RA, SLE, and other illnesses have been presented (<xref ref-type="bibr" rid="ref5">5</xref>). Patients with RA who are exposed to inorganic dust combined with several distinct pulmonary nodules, mainly peripheral to the lung, is called Caplan&#x2019;s syndrome (<xref ref-type="bibr" rid="ref6">6</xref>). At the time of diagnosis, a large number of individuals with Caplan&#x2019;s syndrome had at least mild pneumoconiosis (<xref ref-type="bibr" rid="ref7">7</xref>). According to a case&#x2013;control study conducted in Sweden, women who are exposed to dust have an increased probability of developing gout and may also be at risk for other inflammatory disorders (<xref ref-type="bibr" rid="ref8">8</xref>). This might be relevant to the mechanism of hyperuricemia, the process of sodium urate crystallization, or the inflammatory reaction to the crystals after prolonged exposure to dust. Pneumoconiosis patients have been reported to have a higher level of polyclonal gamma-globulin, particularly IgG, and a high positivity rate for autoantibodies such anti-nuclear antibodies (<xref ref-type="bibr" rid="ref9">9</xref>). Pneumoconiosis is associated with increased autoantibodies, immune complexes, and overproduction of immunoglobulins, including rheumatoid factors (<xref ref-type="bibr" rid="ref10">10</xref>, <xref ref-type="bibr" rid="ref11">11</xref>). Additionally, research on animals has demonstrated that crystalline silica (cSiO<sub>2</sub>) increased the risk of immunological disorders (<xref ref-type="bibr" rid="ref12">12</xref>). Following a week-long exposure to cSiO2, the mice had highly elevated TNF-&#x03B1; levels, acquired autoantigens associated with lupus, and decreased levels in blood IgG, a hallmark of systemic inflammation. And it triggered autoantibodies against the autoantigens&#x2014;collagen II, fibronectin, etc.&#x2014;that are linked to RA. Besides, acute exposure to cSiO2 in lupus-prone mice conduced to lung inflammation, the generation of pro-inflammatory cytokines, and the activation of B- and T-cells, all of which hasten the onset of autoimmune disorders (<xref ref-type="bibr" rid="ref13">13</xref>).</p>
<p>Nevertheless, Studies have constraints in their ability to detect and investigate isolated exposures and are unable to confirm the pathophysiology or causation of pneumoconiosis and inflammatory immune disorders, despite indications of a link between the two diseases. Two-sample Mendelian randomization (MR) method, as an effective method using genetic variation as instrumental variables (IVs), has been used to explore the causal associations between inflammatory immune diseases and other diseases, such as healthy lifestyle, atopic dermatitis, and hormonal factors (<xref ref-type="bibr" rid="ref14 ref15 ref16">14&#x2013;16</xref>). Genetic variation could minimize confounding, give stronger causal reasoning, and overcome some of the limitations of classic observational research since it is unaffected by other variables or the external environment. Therefore, we explored into the causative connections between pneumoconiosis and gout, SLE, and RA using the MR analysis.</p>
</sec>
<sec sec-type="methods" id="sec6">
<label>2</label>
<title>Methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Study design and instrument selection</title>
<p>A two-sample MR study was conducted to find causal relationships. The two-sample MR package in R (version 4.2.3) was used. Since our analysis was based on aggregated summary-level data, ethical approval was unneeded. <xref ref-type="fig" rid="fig1">Figure 1</xref> illustrates our study&#x2019;s assumptions and design. The MR analysis had its basis on three primary assumptions: (1) IVs are supposed to be strongly linked with exposures; (2) they should be independent from confounding factors associated with the relationship between the exposures and outcomes; (3) relevance only through exposures to influence the results (<xref ref-type="bibr" rid="ref17">17</xref>). The flowchart of our study design is shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Diagram of MR study design.</p>
</caption>
<graphic xlink:href="fpubh-12-1373044-g001.tif"/>
</fig>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Flowchart of this MR study. MR: Mendelian randomization; MR-PRESSO: MR-pleiotropy residual sum and outlier.</p>
</caption>
<graphic xlink:href="fpubh-12-1373044-g002.tif"/>
</fig>
<p>Regarding IVs, we chose SNPs that showed a substantial exposure association (<italic>p</italic>&#x2009;&#x003C;&#x2009;5&#x2009;&#x00D7;&#x2009;10<sup>&#x2212;6</sup>). And the <italic>F</italic> and <italic>r</italic><sup>2</sup> values were calculated to ensure each SNP&#x2019;s validity. Linkage disequilibrium (LD) was eliminated in our study (<italic>r</italic><sup>2</sup>&#x2009;&#x003C;&#x2009;0.001, 10,000&#x2009;kb). Palindromic SNPs with intermediate allele frequencies and SNPs with <italic>F</italic>-values &#x003C;10 were removed (<xref ref-type="bibr" rid="ref18">18</xref>). A comprehensive summary of the SNPs that were substantially linked to our exposures was presented in <xref ref-type="supplementary-material" rid="SM1">Supplementary Tables S1&#x2013;S3</xref>.</p>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Data sources</title>
<p>All GWAS data was obtained from the IEU.<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> Two exposures fall into one occupational disease and the GWAS data was from the FinnGen consortium<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref> and the European Bioinformatics Institute GWAS Catalogue.<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref> The exposures we selected including pneumoconiosis (ID: ebi-a-GCST90018900) and pneumoconiosis due to asbestos and other mineral fibers (ID: finn-b-J10_ASBESTPNEUMOC).</p>
<p>Three outcomes&#x2019; GWAS data were all from the European Bioinformatics Institute GWAS Catalogue. The inflammatory immune diseases considered to be analyzed were as follows: SLE (ID: ebi-a-GCST90018917), RA (ID: ebi-a-GCST90038685), and gout (ID: ebi-a-GCST90038687). Since all of the samples were European in origin, there were no racial differences. <xref ref-type="table" rid="tab1">Table 1</xref> presents the exposure and outcome summary information.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Descriptive details and Mendelian randomization estimates of pneumoconiosis and SLE, RA and gout.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Outcome</th>
<th align="left" valign="top">Exposure</th>
<th align="left" valign="top">Ancestry</th>
<th align="left" valign="top">Methods</th>
<th align="center" valign="top">OR</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
<th align="center" valign="top">MR-Egger intercept (<italic>p</italic>-value)</th>
<th align="center" valign="top" colspan="2">Cases</th>
<th align="center" valign="top" colspan="2">Controls</th>
<th align="center" valign="top" colspan="2">Sample size</th>
<th align="center" valign="top" colspan="2">Sources</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th/>
<th align="center" valign="top">Exposure</th>
<th align="center" valign="top">Outcome</th>
<th align="center" valign="top">Exposure</th>
<th align="center" valign="top">Outcome</th>
<th align="center" valign="top">Exposure</th>
<th align="center" valign="top">Outcome</th>
<th align="center" valign="top">Exposure</th>
<th align="center" valign="top">Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">SLE</td>
<td align="left" valign="top" rowspan="3">Pneumoconiosis</td>
<td align="left" valign="middle" rowspan="6">European</td>
<td align="left" valign="middle">IVW</td>
<td align="center" valign="middle">1.01 (0.94&#x2013;1.10)</td>
<td align="center" valign="middle">0.74</td>
<td align="center" valign="middle">0.05 (0.23)</td>
<td align="center" valign="top">433</td>
<td align="center" valign="top">647</td>
<td align="center" valign="top">478,607</td>
<td align="center" valign="top">482,264</td>
<td align="center" valign="top">479,040</td>
<td align="center" valign="top">482,911</td>
<td align="center" valign="top">EBI</td>
<td align="center" valign="top">EBI</td>
</tr>
<tr>
<td/>
<td align="left" valign="middle">MR-Egger</td>
<td align="center" valign="middle">0.93 (0.90&#x2013;1.13)</td>
<td align="center" valign="middle">0.37</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="middle">WM</td>
<td align="center" valign="middle">1.01 (0.80&#x2013;1.08)</td>
<td align="center" valign="middle">0.87</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top" rowspan="3">Pneumoconiosis due to asbestos and other mineral fibers</td>
<td align="left" valign="middle">IVW</td>
<td align="center" valign="middle">1.01 (0.96&#x2013;1.07)</td>
<td align="center" valign="middle">0.66</td>
<td align="center" valign="middle">&#x2212;0.01 (0.88)</td>
<td align="center" valign="top">235</td>
<td/>
<td align="center" valign="top">216,866</td>
<td/>
<td align="center" valign="top">217,101</td>
<td/>
<td align="center" valign="top">FinnGen</td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="middle">MR-Egger</td>
<td align="center" valign="middle">1.02 (0.92&#x2013;1.13)</td>
<td align="center" valign="middle">0.72</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="middle">WM</td>
<td align="center" valign="middle">0.99 (0.92&#x2013;1.07)</td>
<td align="center" valign="middle">0.80</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">RA</td>
<td align="left" valign="top">Pneumoconiosis</td>
<td align="left" valign="middle" rowspan="6">European</td>
<td align="left" valign="middle">IVW</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.50</td>
<td align="center" valign="middle">0.00 (0.66)</td>
<td align="center" valign="top">433</td>
<td align="center" valign="top">5,427</td>
<td align="center" valign="top">478,607</td>
<td align="center" valign="top">479,171</td>
<td align="center" valign="top">479,040</td>
<td align="center" valign="top">484,598</td>
<td align="center" valign="top">EBI</td>
<td align="center" valign="top">EBI</td>
</tr>
<tr>
<td/>
<td/>
<td align="left" valign="middle">MR-Egger</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.48</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td align="left" valign="middle">WM</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.22</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top">Pneumoconiosis due to asbestos and other mineral</td>
<td align="left" valign="middle">IVW</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.68</td>
<td align="center" valign="middle">0.00 (0.19)</td>
<td align="center" valign="top">235</td>
<td/>
<td align="center" valign="top">216,866</td>
<td/>
<td align="center" valign="top">217,101</td>
<td/>
<td align="center" valign="top">FinnGen</td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top">Fibers</td>
<td align="left" valign="middle">MR-Egger</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.43</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td align="left" valign="middle">WM</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.92</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Gout</td>
<td align="left" valign="top">Pneumoconiosis</td>
<td align="left" valign="middle" rowspan="6">European</td>
<td align="left" valign="middle">IVW</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.50</td>
<td align="center" valign="middle">0.00 (0.66)</td>
<td align="center" valign="top">433</td>
<td align="center" valign="top">6,810</td>
<td align="center" valign="top">478,607</td>
<td align="center" valign="top">477,788</td>
<td align="center" valign="top">479,040</td>
<td align="center" valign="top">484,598</td>
<td align="center" valign="top">EBI</td>
<td align="center" valign="top">EBI</td>
</tr>
<tr>
<td/>
<td/>
<td align="left" valign="middle">MR-Egger</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.48</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td align="left" valign="middle">WM</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.22</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top">Pneumoconiosis due to asbestos and other mineral</td>
<td align="left" valign="middle">IVW</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.68</td>
<td align="center" valign="middle">0.00 (0.19)</td>
<td align="center" valign="top">235</td>
<td/>
<td align="center" valign="top">216,866</td>
<td/>
<td align="center" valign="top">217,101</td>
<td/>
<td align="center" valign="top">FinnGen</td>
<td/>
</tr>
<tr>
<td/>
<td align="left" valign="top">fibers</td>
<td align="left" valign="middle">MR-Egger</td>
<td align="center" valign="middle">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="middle">0.43</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td align="left" valign="top">WM</td>
<td align="center" valign="top">1.00 (1.00&#x2013;1.00)</td>
<td align="center" valign="top">0.92</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>EBI: European Bioinformatics Institute; IVW: inverse variance weighted; WM: Weighted median; OR: odd ratios; CI: CONFIDENCE interval.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec9">
<label>2.3</label>
<title>Statistical analysis</title>
<p>The MR-Egger method, weighted median (WM), inverse variance weighted (IVW) method, simple mode, and weighted mode were the methods employed. And the main analytical approach used to evaluate the causal links was the IVW method. Besides, the chosen SNPs had no connection to smoking or alcohol consumption, which may be confounding factors for inflammatory immune diseases.</p>
<p>For validation of the accuracy of the results we obtained, sensitivity analyses involving the Cochran&#x2019;s Q test, MR-PRESSO, MR-Egger regression, and leave-one-out analysis were performed. Cochran&#x2019;s Q test was utilized to assess SNPS heterogeneity (<italic>p</italic>&#x2009;&#x003E;&#x2009;0.05 indicates no heterogeneity) (<xref ref-type="bibr" rid="ref19">19</xref>). Genetic diversity that influences outcomes through alternative pathways is known as pleiotropy (<xref ref-type="bibr" rid="ref20">20</xref>). With MR-PRESSO, pleiotropy at the gene level was examined. It adjusts for the influence of genetic variants on causal estimates and identifies variants with pleiotropic effects. The presence of pleiotropy was also assessed by applying MR-Egger regression. An intercept that is statistically significant is able to identify pleiotropy. It computes the linear regression of the genetic variations on the outcome. To assess the overall influence of certain genetic variations, a leave-one-out analysis was used. The removal of one genetic variant at a time can be done with this method. Furthermore, by recalculating the causal estimate, the effect of each unique genetic variation may be determined (<xref ref-type="bibr" rid="ref21">21</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="sec10">
<label>3</label>
<title>Results</title>
<sec id="sec11">
<label>3.1</label>
<title>MR analysis of pneumoconiosis on SLE</title>
<p>No causal association was discovered in results of pneumoconiosis, pneumoconiosis due to asbestos and other mineral fibers on SLE, listed in <xref ref-type="table" rid="tab1">Table 1</xref>, using the IVW method (OR: 1.01, <italic>p</italic>&#x2009;=&#x2009;0.74; OR: 1.01, <italic>p</italic>&#x2009;=&#x2009;0.66). This correlation was also not detected using the WM method and MR-Egger approach (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1A,B</xref>). We consider that our results are credible because there was no significant heterogeneity (<italic>p</italic>&#x2009;=&#x2009;0.50; <italic>p</italic>&#x2009;=&#x2009;0.57) and no horizontal pleiotropy (<italic>p</italic>&#x2009;=&#x2009;0.23; <italic>p</italic>&#x2009;=&#x2009;0.88) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S2A,B</xref>). The forest plot is showed in <xref ref-type="fig" rid="fig3">Figure 3</xref>. The stability of the MR estimates was further validated through a leave-out test (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S3A,B</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Forest plot of SNPs associated with pneumoconiosis and pneumoconiosis due to asbestos and other mineral fibers and their risk on SLE.</p>
</caption>
<graphic xlink:href="fpubh-12-1373044-g003.tif"/>
</fig>
</sec>
<sec id="sec12">
<label>3.2</label>
<title>MR analysis of pneumoconiosis on RA</title>
<p>Using the IVW approach, no statistically significant association was found in results on RA, presented in <xref ref-type="table" rid="tab1">Table 1</xref> (OR: 1.00, <italic>p</italic>&#x2009;=&#x2009;0.50; OR: 1.00, <italic>p</italic>&#x2009;=&#x2009;0.68). The WM and the MR-Egger method similarly failed to find this relationship (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1C,D</xref>). There was no significant heterogeneity (<italic>p</italic>&#x2009;=&#x2009;0.38; <italic>p</italic>&#x2009;=&#x2009;0.18) and no horizontal pleiotropy (<italic>p</italic>&#x2009;=&#x2009;0.66; <italic>p</italic>&#x2009;=&#x2009;0.19) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S2C,D</xref>). The forest plot is depicted in <xref ref-type="fig" rid="fig4">Figure 4</xref>. A leave-out test was used to confirm the stability of the MR estimations (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S3C,D</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Forest plot of SNPs associated with pneumoconiosis and pneumoconiosis due to asbestos and their risk on RA.</p>
</caption>
<graphic xlink:href="fpubh-12-1373044-g004.tif"/>
</fig>
</sec>
<sec id="sec13">
<label>3.3</label>
<title>MR analysis of pneumoconiosis on gout</title>
<p>No causal relationship was found in results on gout, displayed in <xref ref-type="table" rid="tab1">Table 1</xref>, using the IVW method (OR: 1.00, <italic>p</italic>&#x2009;=&#x2009;0.55; OR: 1.00, <italic>p</italic>&#x2009;=&#x2009;0.20). This correlation was also failed to find using the WM method and MR-Egger approach (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1E,F</xref>). Pneumoconiosis had heterogeneous outcomes for gout, while pneumoconiosis due to asbestos and other mineral fibers did not (<italic>p</italic>&#x2009;=&#x2009;0.01; <italic>p</italic>&#x2009;=&#x2009;0.47). Our analysis indicated no horizontal pleiotropy (<italic>p</italic>&#x2009;=&#x2009;0.19; <italic>p</italic>&#x2009;=&#x2009;0.77) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S2E,F</xref>). The forest plot is showed in <xref ref-type="fig" rid="fig5">Figure 5</xref>. A leave-out test was applied to assess the stability of the MR estimates (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S3E,F</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Forest plot of SNPs associated with pneumoconiosis and pneumoconiosis due to asbestos and their risk on gout.</p>
</caption>
<graphic xlink:href="fpubh-12-1373044-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec14">
<label>4</label>
<title>Discussion</title>
<p>To our knowledge, this is the first study to investigate the causal connection between pneumoconiosis and inflammatory immune diseases. Our results indicates that pneumoconiosis and SLE, RA, and gout are not causally related. Nevertheless, further research is needed to validate and clarify the mechanism.</p>
<p>Although the etiology and pathogenesis of inflammatory immune diseases are still unclear, they might be related to environmental factors. In some investigations, the development of RA, SLE, and other inflammatory immunological disorders is linked to occupational exposure to external airborne agents (EAA) (<xref ref-type="bibr" rid="ref22">22</xref>). Workers in different manufacturing and construction sectors, as well as miners and quarry workers, might be frequently exposed to EAA, including cSiO<sub>2</sub>, asbestos, and steam (<xref ref-type="bibr" rid="ref23">23</xref>). Pneumoconiosis is triggered directly by exposure to cSiO2 (a major factor), asbestos, etc. These elements have been linked to an elevated incidence and severity of inflammatory immunological disorders (<xref ref-type="bibr" rid="ref2">2</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). These environmental pollutants can be used as a molecular pattern that causes damage once they enter the human body, producing the autoinflammatory response that is typified by increased production of reactive oxygen species, increased macrophage flux, NF-&#x03BA;B activation, tumor necrosis factor, IL-1&#x03B2;, and IL-6, among other pro-inflammatory cytokines (<xref ref-type="bibr" rid="ref25">25</xref>). These triggers cause B cells and dendritic cells to get stimulated, which in turn produces a lot of antibodies and autoreactive T lymphocytes. This destroys immunological tolerance and causes inflammatory immune diseases (<xref ref-type="bibr" rid="ref26">26</xref>, <xref ref-type="bibr" rid="ref27">27</xref>).</p>
<p>New Zealand mixed mice exposed to silicate showed reduced blood IgG, a biomarker of systemic inflammation, and lifted growth of TNF-&#x03B1;, IL-6, B-cell activating factor, and IgM. Further still, cSiO<sub>2</sub> also causes an autoantibody reaction to autoantigens linked to RA and SLE (<xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref29">29</xref>). Pneumoconiosis patients&#x2019; serum cytokine analysis also led to some discoveries. Serum IL-6 appeared to be included in the same factor as ANCA levels and antinuclear antibody titers. Apart from boosting responder T cells and lowering Treg cells, IL-6 also contributes a great deal to T helper cell polarization towards Th17 cells, preventing cSiO<sub>2</sub>-induced lung inflammation via an IL-1B-dependent pathway (<xref ref-type="bibr" rid="ref30">30</xref>, <xref ref-type="bibr" rid="ref31">31</xref>). The predominant factor influencing the level of inflammation is the fraction of quartz, a part of the respirable dust responsible for coal dust (<xref ref-type="bibr" rid="ref32">32</xref>). However, a number of studies consistently demonstrate that the development of pneumoconiosis is not influenced by the quartz concentration of mixed dust. For instance, pneumoconiosis is less common in German coal mines where quartz concentrations are greater (<xref ref-type="bibr" rid="ref33">33</xref>). Conversely, a coal mine with a lower proportion of quartz was shown to have a higher prevalence of pneumoconiosis (<xref ref-type="bibr" rid="ref34">34</xref>). In French miners, high quartz concentrations have not been linked to pulmonary fibrosis (<xref ref-type="bibr" rid="ref35">35</xref>). A review goes into great length on animal studies, <italic>in vitro</italic> evaluations, and epidemiological evidence supporting the hypothesis that iron concentration in coal, not quartz, raises the risk of pneumoconiosis in coal miners (<xref ref-type="bibr" rid="ref36">36</xref>). It also mentioned that a potential biomarker might be the changed ferritin levels that coal workers experience after taking in coal dust. Moreover, clay samples significantly inhibited quartz-induced lung inflammation (<xref ref-type="bibr" rid="ref37">37</xref>). Thus, the entire burden of pneumoconiosis may be entirely attributed to occupational exposure to gases, smoke, and particulate matter through risk factors (<xref ref-type="bibr" rid="ref38">38</xref>). Rather than inflammation, the degree of occupational exposure concentration and exposure duration plays an essential part in the development and course of pneumoconiosis (<xref ref-type="bibr" rid="ref39">39</xref>). Information on blood markers of systemic inflammation is not available in the database. Lung inflammation due to quartz content in inhaled dust may not cause a high lung burden or develop pneumoconiosis (<xref ref-type="bibr" rid="ref40">40</xref>). Therefore, our study suggests that there is no causal relationship between pneumoconiosis and the three inflammatory immune diseases.</p>
<p>There are several limitations in previous observational studies. Firstly, the number of cases of SLE, RA, and gout caused by pneumoconiosis may have been underestimated and misclassified because the patients included were mainly diagnosed as outpatients. Secondly, many studies lacked case information and were therefore unable to control for relevant confounders, including family history and lifestyles. Thirdly, the history of dust exposure was incomplete, including information regarding the usage of personal protective equipment, which is the optimum approach for reducing cSiO2 exposure and preventing pneumoconiosis in workers.</p>
<p>There are also some limitations in our study to consider. First, we relaxed the selection criterion (<italic>p</italic>&#x2009;&#x003C;&#x2009;5&#x2009;&#x00D7;&#x2009;10<sup>&#x2212;6</sup>, <italic>r</italic><sup>2</sup>&#x2009;=&#x2009;0.001, kb&#x2009;=&#x2009;10,000) as there were not numerous SNPS that fit the inclusion requirements. This might result in some false positives. Besides, the study focused on European populations, and it is unknown if other populations show the same link. Finally, we did not obtain GWAS data for pneumoconiosis caused by other exposures, and etiological categorization could not be analyzed. In conclusion, we did not find a causal relationship between pneumoconiosis and the three inflammatory immune diseases.</p>
</sec>
<sec sec-type="data-availability" id="sec15">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="sec16">
<title>Author contributions</title>
<p>Y-JD: Writing &#x2013; original draft. Z-WL: Writing &#x2013; original draft. K-DL: Writing &#x2013; original draft. Y-YuW: Writing &#x2013; original draft. HW: Writing &#x2013; original draft. R-GH: Writing &#x2013; original draft. XJ: Writing &#x2013; original draft. Y-YuaW: Writing &#x2013; original draft. JW: Writing &#x2013; original draft. A-YG: Writing &#x2013; original draft. B-ZL: Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec17">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (81803310); the Research Fund of Anhui Institute of translational Medicine (2021zhyx-C21); Center for Big Data and Population Health of IHM (JKS2022023); Clinical Medical Research Transformation Project in Anhui Province (202304295107020026); the Peak Discipline of Public Health and Preventive Medicine, Anhui Medical University.</p>
</sec>
<ack>
<p>We appreciate all the volunteers who participated in this study. We are grateful to the Open GWAS for providing GWAS summary statistics.</p>
</ack>
<sec sec-type="COI-statement" id="sec18">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec19">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fpubh.2024.1373044/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fpubh.2024.1373044/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<fn-group>
<fn id="fn0001">
<p><sup>1</sup><ext-link xlink:href="https://gwas.mrcieu.ac.uk/" ext-link-type="uri">https://gwas.mrcieu.ac.uk/</ext-link></p>
</fn>
<fn id="fn0002">
<p><sup>2</sup><ext-link xlink:href="https://www.finngen.fi/fi" ext-link-type="uri">https://www.finngen.fi/fi</ext-link></p>
</fn>
<fn id="fn0003">
<p><sup>3</sup><ext-link xlink:href="https://www.ebi.ac.uk/" ext-link-type="uri">https://www.ebi.ac.uk/</ext-link></p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname> <given-names>KM</given-names></name></person-group>. <article-title>Silica, silicosis, and autoimmunity</article-title>. <source>Front Immunol</source>. (<year>2016</year>) <volume>7</volume>:<fpage>97</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2016.00097</pub-id>, PMID: <pub-id pub-id-type="pmid">27014276</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stolt</surname> <given-names>P</given-names></name> <name><surname>K&#x00E4;llberg</surname> <given-names>H</given-names></name> <name><surname>Lundberg</surname> <given-names>I</given-names></name> <name><surname>Sj&#x00F6;gren</surname> <given-names>B</given-names></name> <name><surname>Klareskog</surname> <given-names>L</given-names></name> <name><surname>Alfredsson</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study</article-title>. <source>Ann Rheum Dis</source>. (<year>2005</year>) <volume>64</volume>:<fpage>582</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1136/ard.2004.022053</pub-id>, PMID: <pub-id pub-id-type="pmid">15319232</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S</given-names></name> <name><surname>Ma</surname> <given-names>X</given-names></name> <name><surname>Lee</surname> <given-names>W</given-names></name></person-group>. <article-title>Association between exposure to external airborne agents and autoimmune disease</article-title>. <source>Ecotoxicol Environ Saf</source>. (<year>2023</year>) <volume>263</volume>:<fpage>115334</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ecoenv.2023.115334</pub-id>, PMID: <pub-id pub-id-type="pmid">37567098</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Sundquist</surname> <given-names>J</given-names></name> <name><surname>Sundquist</surname> <given-names>K</given-names></name> <name><surname>Z&#x00F6;ller</surname> <given-names>B</given-names></name></person-group>. <article-title>Occupational risk factors for systemic lupus erythematosus: a nationwide study based on hospitalizations in Sweden</article-title>. <source>J Rheumatol</source>. (<year>2012</year>) <volume>39</volume>:<fpage>743</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.3899/jrheum.110789</pub-id>, PMID: <pub-id pub-id-type="pmid">22382347</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname> <given-names>Y</given-names></name> <name><surname>Tomita</surname> <given-names>M</given-names></name> <name><surname>Yoshino</surname> <given-names>I</given-names></name> <name><surname>Hosoda</surname> <given-names>Y</given-names></name></person-group>. <article-title>Relationship between autoimmune diseases and pneumoconiosis</article-title>. <source>Sangyo Igaku</source>. (<year>1992</year>) <volume>34</volume>:<fpage>421</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1539/joh1959.34.421</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname> <given-names>J</given-names></name> <name><surname>Koschel</surname> <given-names>D</given-names></name> <name><surname>Kekow</surname> <given-names>J</given-names></name> <name><surname>Waldburg</surname> <given-names>N</given-names></name> <name><surname>Goette</surname> <given-names>A</given-names></name> <name><surname>Merget</surname> <given-names>R</given-names></name></person-group>. <article-title>Rheumatoid pneumoconiosis (Caplan&#x2019;s syndrome)</article-title>. <source>Eur J Intern Med</source>. (<year>2010</year>) <volume>21</volume>:<fpage>168</fpage>&#x2013;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejim.2010.02.004</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Honma</surname> <given-names>K</given-names></name> <name><surname>Vallyathan</surname> <given-names>V</given-names></name></person-group>. <article-title>Rheumatoid pneumoconiosis: a comparative study of autopsy cases between Japan and North America</article-title>. <source>Ann Occup Hyg</source>. (<year>2002</year>) <volume>46</volume>:<fpage>265</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1093/annhyg/46</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sigurdardottir</surname> <given-names>V</given-names></name> <name><surname>Jacobsson</surname> <given-names>L</given-names></name> <name><surname>Schi&#x00F6;ler</surname> <given-names>L</given-names></name> <name><surname>Sv&#x00E4;rd</surname> <given-names>A</given-names></name> <name><surname>Dehlin</surname> <given-names>M</given-names></name> <name><surname>Toren</surname> <given-names>K</given-names></name></person-group>. <article-title>Occupational exposure to inorganic dust and risk of gout: a population-based study</article-title>. <source>RMD Open</source>. (<year>2020</year>) <volume>6</volume>:<fpage>e001178</fpage>. doi: <pub-id pub-id-type="doi">10.1136/rmdopen-2020-001178</pub-id>, PMID: <pub-id pub-id-type="pmid">32683325</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bas</surname> <given-names>S</given-names></name> <name><surname>Genevay</surname> <given-names>S</given-names></name> <name><surname>Meyer</surname> <given-names>O</given-names></name> <name><surname>Gabay</surname> <given-names>C</given-names></name></person-group>. <article-title>Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis</article-title>. <source>Rheumatology</source>. (<year>2003</year>) <volume>42</volume>:<fpage>677</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1093/rheumatology/keg184</pub-id>, PMID: <pub-id pub-id-type="pmid">12709545</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lakos</surname> <given-names>G</given-names></name> <name><surname>Soos</surname> <given-names>L</given-names></name> <name><surname>Fekete</surname> <given-names>A</given-names></name> <name><surname>Szabo</surname> <given-names>Z</given-names></name> <name><surname>Zeher</surname> <given-names>M</given-names></name> <name><surname>Horvath</surname> <given-names>IF</given-names></name> <etal/></person-group>. <article-title>Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope</article-title>. <source>Clin Exp Rheumatol</source>. (<year>2008</year>) <volume>26</volume>:<fpage>253</fpage>&#x2013;<lpage>60</lpage>. PMID: <pub-id pub-id-type="pmid">18565246</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pernis</surname> <given-names>B</given-names></name></person-group>. <article-title>Silica and the immune system</article-title>. <source>Acta Biomed</source>. (<year>2005</year>) <volume>76</volume>:<fpage>38</fpage>&#x2013;<lpage>44</lpage>.</citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname> <given-names>PS</given-names></name> <name><surname>Wagner</surname> <given-names>JG</given-names></name> <name><surname>Benninghoff</surname> <given-names>AD</given-names></name> <name><surname>Lewandowski</surname> <given-names>RP</given-names></name> <name><surname>Favor</surname> <given-names>OK</given-names></name> <name><surname>Wierenga</surname> <given-names>KA</given-names></name> <etal/></person-group>. <article-title>Rapid induction of pulmonary inflammation, autoimmune gene expression, and ectopic lymphoid Neogenesis following acute silica exposure in lupus-prone mice</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>635138</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.635138</pub-id>, PMID: <pub-id pub-id-type="pmid">33732257</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gottschalk</surname> <given-names>TA</given-names></name> <name><surname>Tsantikos</surname> <given-names>E</given-names></name> <name><surname>Hibbs</surname> <given-names>ML</given-names></name></person-group>. <article-title>Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus</article-title>. <source>Front Immunol</source>. (<year>2015</year>) <volume>6</volume>:<fpage>550</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2015.00550</pub-id>, PMID: <pub-id pub-id-type="pmid">26579125</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname> <given-names>Z</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Zu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Systemic lupus erythematosus and atopic dermatitis: a two sample Mendelian randomization study</article-title>. <source>Clin Rheumatol</source>. (<year>2024</year>) <volume>43</volume>:<fpage>1311</fpage>&#x2013;<lpage>1317</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10067-024-06900-z</pub-id>, PMID: <pub-id pub-id-type="pmid">38349447</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Fang</surname> <given-names>XY</given-names></name> <name><surname>Leng</surname> <given-names>R</given-names></name> <name><surname>Chen</surname> <given-names>HF</given-names></name> <name><surname>Qian</surname> <given-names>TT</given-names></name> <name><surname>Cai</surname> <given-names>YY</given-names></name> <etal/></person-group>. <article-title>Metabolic signature of healthy lifestyle and risk of rheumatoid arthritis: observational and Mendelian randomization study</article-title>. <source>Am J Clin Nutr</source>. (<year>2023</year>) <volume>118</volume>:<fpage>183</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajcnut.2023.04.034</pub-id>, PMID: <pub-id pub-id-type="pmid">37127109</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>LQ</given-names></name> <name><surname>Zhang</surname> <given-names>RD</given-names></name> <name><surname>Musonye</surname> <given-names>HA</given-names></name> <name><surname>Zhao</surname> <given-names>HY</given-names></name> <name><surname>He</surname> <given-names>YS</given-names></name> <name><surname>Zhao</surname> <given-names>CN</given-names></name> <etal/></person-group>. <article-title>Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223&#x2009;526 participants</article-title>. <source>RMD Open</source>. (<year>2024</year>) <volume>10</volume>:<fpage>e003338</fpage>. doi: <pub-id pub-id-type="doi">10.1136/rmdopen-2023-003338</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemani</surname> <given-names>G</given-names></name> <name><surname>Zheng</surname> <given-names>J</given-names></name> <name><surname>Elsworth</surname> <given-names>B</given-names></name> <name><surname>Wade</surname> <given-names>KH</given-names></name> <name><surname>Haberland</surname> <given-names>V</given-names></name> <name><surname>Baird</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>The MR-base platform supports systematic causal inference across the human phenome</article-title>. <source>eLife</source>. (<year>2018</year>) <volume>7</volume>:<fpage>e34408</fpage>. doi: <pub-id pub-id-type="doi">10.7554/eLife.34408</pub-id>, PMID: <pub-id pub-id-type="pmid">29846171</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname> <given-names>TM</given-names></name> <name><surname>Lawlor</surname> <given-names>DA</given-names></name> <name><surname>Harbord</surname> <given-names>RM</given-names></name> <name><surname>Sheehan</surname> <given-names>NA</given-names></name> <name><surname>Tobias</surname> <given-names>JH</given-names></name> <name><surname>Timpson</surname> <given-names>NJ</given-names></name> <etal/></person-group>. <article-title>Using multiple genetic variants as instrumental variables for modifiable risk factors</article-title>. <source>Stat Methods Med Res</source>. (<year>2012</year>) <volume>21</volume>:<fpage>223</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0962280210394459</pub-id>, PMID: <pub-id pub-id-type="pmid">21216802</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname> <given-names>J</given-names></name> <name><surname>Del Greco</surname> <given-names>MF</given-names></name> <name><surname>Minelli</surname> <given-names>C</given-names></name> <name><surname>Davey Smith</surname> <given-names>G</given-names></name> <name><surname>Sheehan</surname> <given-names>N</given-names></name> <name><surname>Thompson</surname> <given-names>J</given-names></name></person-group>. <article-title>A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization</article-title>. <source>Stat Med</source>. (<year>2017</year>) <volume>36</volume>:<fpage>1783</fpage>&#x2013;<lpage>802</lpage>. doi: <pub-id pub-id-type="doi">10.1002/sim.7221</pub-id>, PMID: <pub-id pub-id-type="pmid">28114746</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verbanck</surname> <given-names>M</given-names></name> <name><surname>Chen</surname> <given-names>CY</given-names></name> <name><surname>Neale</surname> <given-names>B</given-names></name> <name><surname>Do</surname> <given-names>R</given-names></name></person-group>. <article-title>Publisher correction: detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases</article-title>. <source>Nat Genet</source>. (<year>2018</year>) <volume>50</volume>:<fpage>1196</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41588-018-0164-2</pub-id>, PMID: <pub-id pub-id-type="pmid">29967445</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hemani</surname> <given-names>G</given-names></name> <name><surname>Tilling</surname> <given-names>K</given-names></name> <name><surname>Davey</surname> <given-names>SG</given-names></name></person-group>. <article-title>Correction: orienting the causal relationship between imprecisely measured traits using GWAS summary data</article-title>. <source>PLoS Genet</source>. (<year>2017</year>) <volume>13</volume>:<fpage>e1007149</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1007149</pub-id>, PMID: <pub-id pub-id-type="pmid">29287073</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Celen</surname> <given-names>H</given-names></name> <name><surname>Dens</surname> <given-names>AC</given-names></name> <name><surname>Ronsmans</surname> <given-names>S</given-names></name> <name><surname>Michiels</surname> <given-names>S</given-names></name> <name><surname>De Langhe</surname> <given-names>E</given-names></name></person-group>. <article-title>Airborne pollutants as potential triggers of systemic autoimmune rheumatic diseases: a narrative review</article-title>. <source>Acta Clin Belg</source>. (<year>2022</year>) <volume>77</volume>:<fpage>874</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1080/17843286.2021.1992582</pub-id>, PMID: <pub-id pub-id-type="pmid">34666637</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tor&#x00E9;n</surname> <given-names>K</given-names></name> <name><surname>Blanc</surname> <given-names>PD</given-names></name> <name><surname>Naidoo</surname> <given-names>R</given-names></name> <name><surname>Murgia</surname> <given-names>N</given-names></name> <name><surname>Stockfelt</surname> <given-names>L</given-names></name> <name><surname>Schi&#x00F6;ler</surname> <given-names>L</given-names></name></person-group>. <article-title>Cumulative occupational exposure to inorganic dust and fumes and invasive pneumococcal disease with pneumonia</article-title>. <source>Int Arch Occup Environ Health</source>. (<year>2022</year>) <volume>95</volume>:<fpage>1797</fpage>&#x2013;<lpage>804</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00420-022-01848-6</pub-id>, PMID: <pub-id pub-id-type="pmid">35262802</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S</given-names></name> <name><surname>Hayashi</surname> <given-names>H</given-names></name> <name><surname>Mastuzaki</surname> <given-names>H</given-names></name> <name><surname>Kumagai-Takei</surname> <given-names>N</given-names></name> <name><surname>Otsuki</surname> <given-names>T</given-names></name></person-group>. <article-title>Silicosis and autoimmunity</article-title>. <source>Curr Opin Allergy Clin Immunol</source>. (<year>2017</year>) <volume>17</volume>:<fpage>78</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1097/ACI.0000000000000350</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrag&#x00E1;n-Mart&#x00ED;nez</surname> <given-names>C</given-names></name> <name><surname>Speck-Hern&#x00E1;ndez</surname> <given-names>CA</given-names></name> <name><surname>Montoya-Ortiz</surname> <given-names>G</given-names></name> <name><surname>Mantilla</surname> <given-names>RD</given-names></name> <name><surname>Anaya</surname> <given-names>JM</given-names></name> <name><surname>Rojas-Villarraga</surname> <given-names>A</given-names></name></person-group>. <article-title>Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis</article-title>. <source>PLoS One</source>. (<year>2012</year>) <volume>7</volume>:<fpage>e51506</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0051506</pub-id>, PMID: <pub-id pub-id-type="pmid">23284705</pub-id></citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayeux</surname> <given-names>JM</given-names></name> <name><surname>Escalante</surname> <given-names>GM</given-names></name> <name><surname>Christy</surname> <given-names>JM</given-names></name> <name><surname>Pawar</surname> <given-names>RD</given-names></name> <name><surname>Kono</surname> <given-names>DH</given-names></name> <name><surname>Pollard</surname> <given-names>KM</given-names></name></person-group>. <article-title>Silicosis and silica-induced autoimmunity in the diversity outbred mouse</article-title>. <source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<fpage>874</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.00874</pub-id>, PMID: <pub-id pub-id-type="pmid">29755467</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x00E4;llberg</surname> <given-names>H</given-names></name> <name><surname>Ding</surname> <given-names>B</given-names></name> <name><surname>Padyukov</surname> <given-names>L</given-names></name> <name><surname>Bengtsson</surname> <given-names>C</given-names></name> <name><surname>R&#x00F6;nnelid</surname> <given-names>J</given-names></name> <name><surname>Klareskog</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke</article-title>. <source>Ann Rheum Dis</source>. (<year>2011</year>) <volume>70</volume>:<fpage>508</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1136/ard.2009.120899</pub-id>, PMID: <pub-id pub-id-type="pmid">21149499</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>JM</given-names></name> <name><surname>Archer</surname> <given-names>AJ</given-names></name> <name><surname>Pfau</surname> <given-names>JC</given-names></name> <name><surname>Holian</surname> <given-names>A</given-names></name></person-group>. <article-title>Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice</article-title>. <source>Clin Exp Immunol</source>. (<year>2003</year>) <volume>131</volume>:<fpage>415</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2249.2003.02094</pub-id>, PMID: <pub-id pub-id-type="pmid">12605693</pub-id></citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname> <given-names>MA</given-names></name> <name><surname>Brandenberger</surname> <given-names>C</given-names></name> <name><surname>Langohr</surname> <given-names>I</given-names></name> <name><surname>Kumagai</surname> <given-names>K</given-names></name> <name><surname>Harkema</surname> <given-names>JR</given-names></name> <name><surname>Holian</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Silica triggers inflammation and ectopic lymphoid neogenesis in the lungs in parallel with accelerated onset of systemic autoimmunity and glomerulonephritis in the lupus-prone NZBWF1 mouse</article-title>. <source>PLoS One</source>. (<year>2015</year>) <volume>10</volume>:<fpage>e0125481</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0125481</pub-id>, PMID: <pub-id pub-id-type="pmid">25978333</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lo Re</surname> <given-names>S</given-names></name> <name><surname>Dumoutier</surname> <given-names>L</given-names></name> <name><surname>Couillin</surname> <given-names>I</given-names></name> <name><surname>van Vyve</surname> <given-names>C</given-names></name> <name><surname>Yakoub</surname> <given-names>Y</given-names></name> <name><surname>Uwambayinema</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>184</volume>:<fpage>6367</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.0900459</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>L</given-names></name> <name><surname>Weng</surname> <given-names>D</given-names></name> <name><surname>Dai</surname> <given-names>W</given-names></name> <name><surname>Tang</surname> <given-names>W</given-names></name> <name><surname>Chen</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Th17 can regulate silica-induced lung inflammation through an IL-1b-dependent mechanism</article-title>. <source>J Cell Mol Med</source>. (<year>2014</year>) <volume>18</volume>:<fpage>1773</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jcmm.12341</pub-id>, PMID: <pub-id pub-id-type="pmid">25091058</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="other"><person-group person-group-type="author"><name><surname>Walton</surname> <given-names>WH</given-names></name> <name><surname>Dodgson</surname> <given-names>J</given-names></name> <name><surname>Hadden</surname> <given-names>GG</given-names></name> <name><surname>Jacobsen</surname> <given-names>M</given-names></name></person-group>. <article-title>The effect of quartz and other non-coal dusts in coal workers&#x2019; pneumoconiosis</article-title>. ln: <person-group person-group-type="editor"><name><surname>Walton</surname> <given-names>WH</given-names></name></person-group>, ed, <source>Inhaled particles IV, old Woking</source>, <publisher-loc>United Kingdom</publisher-loc>: <publisher-name>Unwin Brothers</publisher-name>. (<year>1977</year>) p. <fpage>669</fpage>&#x2013;<lpage>689</lpage>.</citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="book"><person-group person-group-type="author"><name><surname>Lebouffant</surname> <given-names>L</given-names></name> <name><surname>Daniel</surname> <given-names>H</given-names></name> <name><surname>Martin</surname> <given-names>JC</given-names></name></person-group>. <article-title>Quartz as a Causative Agent in Pneumoconiotic Lesions in Coal Miners</article-title>. In: <source>Industrial health and medicine series, No. 19</source>. <publisher-loc>Luxembourg</publisher-loc>: <publisher-name>Commission of the European communities-ESC</publisher-name> (<year>1977</year>). <fpage>1</fpage>&#x2013;<lpage>60</lpage>.</citation></ref>
<ref id="ref34"><label>34.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname> <given-names>JF</given-names></name> <name><surname>Burns</surname> <given-names>J</given-names></name> <name><surname>Copland</surname> <given-names>L</given-names></name> <name><surname>Dodgson</surname> <given-names>J</given-names></name> <name><surname>Jacobsen</surname> <given-names>M</given-names></name></person-group>. <article-title>Coal workers&#x2019; with simple pneumoconiosis with exposure to dust at 10 British coalmines</article-title>. <source>Br J Ind Med</source>. (<year>1982</year>) <volume>39</volume>:<fpage>120</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1136/oem.39.2.120</pub-id>, PMID: <pub-id pub-id-type="pmid">7066228</pub-id></citation></ref>
<ref id="ref35"><label>35.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rivers</surname> <given-names>D</given-names></name> <name><surname>Wise</surname> <given-names>ME</given-names></name> <name><surname>King</surname> <given-names>EJ</given-names></name> <name><surname>Nagelschmidt</surname> <given-names>G</given-names></name></person-group>. <article-title>Dust content, radiology and pathology in simple pneumoconiosis of coal workers&#x2019;</article-title>. <source>Br J Occup Med</source>. (<year>1960</year>) <volume>17</volume>:<fpage>87</fpage>&#x2013;<lpage>108</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-1-4832-1329-3.50041-X</pub-id></citation></ref>
<ref id="ref36"><label>36.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCunney</surname> <given-names>RJ</given-names></name> <name><surname>Morfeld</surname> <given-names>P</given-names></name> <name><surname>Payne</surname> <given-names>S</given-names></name></person-group>. <article-title>What component of coal causes coal workers&#x2019; pneumoconiosis?</article-title> <source>J Occup Environ Med</source>. (<year>2009</year>) <volume>51</volume>:<fpage>462</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1097/JOM.0b013e3181a01ada</pub-id>, PMID: <pub-id pub-id-type="pmid">19333134</pub-id></citation></ref>
<ref id="ref37"><label>37.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname> <given-names>V</given-names></name> <name><surname>Jones</surname> <given-names>R</given-names></name> <name><surname>Rollo</surname> <given-names>K</given-names></name> <name><surname>Duffin</surname> <given-names>R</given-names></name> <name><surname>Donaldson</surname> <given-names>K</given-names></name> <name><surname>Brown</surname> <given-names>DM</given-names></name></person-group>. <article-title>Effect of coal mine dust and clay extracts on the biological activity of the quartz surface</article-title>. <source>Toxicol Lett</source>. (<year>2004</year>) <volume>149</volume>:<fpage>255</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.toxlet.2003.12.036</pub-id>, PMID: <pub-id pub-id-type="pmid">15093271</pub-id></citation></ref>
<ref id="ref38"><label>38.</label> <citation citation-type="journal"><person-group person-group-type="author"><collab id="coll1">GBD 2016 Risk Factors Collaborators</collab></person-group>. <article-title>Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the global burden of disease study 2016</article-title>. <source>Lancet</source>. (<year>2017</year>) <volume>390</volume>:<fpage>1345</fpage>&#x2013;<lpage>422</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(17)32366-8</pub-id></citation></ref>
<ref id="ref39"><label>39.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schl&#x00FC;nssen</surname> <given-names>V</given-names></name> <name><surname>Mandrioli</surname> <given-names>D</given-names></name> <name><surname>Pega</surname> <given-names>F</given-names></name> <name><surname>Momen</surname> <given-names>NC</given-names></name> <name><surname>&#x00C1;d&#x00E1;m</surname> <given-names>B</given-names></name> <name><surname>Chen</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>The prevalences and levels of occupational exposure to dusts and/or fibers (silica, asbestos and coal): a systematic review and meta-analysis from the WHO/ILO joint estimates of the work-related burden of disease and injury</article-title>. <source>Environ Int</source>. (<year>2023</year>) <volume>178</volume>:<fpage>107980</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.envint.2023.107980</pub-id>, PMID: <pub-id pub-id-type="pmid">37487377</pub-id></citation></ref>
<ref id="ref40"><label>40.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCunney</surname> <given-names>RJ</given-names></name> <name><surname>Yong</surname> <given-names>M</given-names></name></person-group>. <article-title>Coal miners and lung Cancer: can mortality studies offer a perspective on rat inhalation studies of poorly soluble low toxicity particles?</article-title> <source>Front Public Health</source>. (<year>2022</year>) <volume>10</volume>:<fpage>907157</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2022.907157</pub-id>, PMID: <pub-id pub-id-type="pmid">35910918</pub-id></citation></ref>
</ref-list>
</back>
</article>